Literature DB >> 28257888

Polo-like kinase 2 phosphorylation of amyloid precursor protein regulates activity-dependent amyloidogenic processing.

Yeunkum Lee1, Ji Soo Lee2, Kea Joo Lee3, R Scott Turner4, Hyang-Sook Hoe5, Daniel T S Pak6.   

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder with cognitive deficits. Amyloidogenic processing of amyloid precursor protein (APP) produces amyloid β (Aβ), the major component of hallmark AD plaques. Synaptic activity stimulates APP cleavage, whereas APP promotes excitatory synaptic transmission, suggesting APP participates in neuronal homeostasis. However, mechanisms linking synaptic activity to APP processing are unclear. Here we show that Polo-like kinase 2 (Plk2), an activity-inducible regulator of homeostatic plasticity, directly binds and phosphorylates threonine-668 and serine-675 of APP in vitro and associates with APP in vivo. Plk2 accelerates APP amyloidogenic cleavage by β-secretase at synapses and is required for neuronal overactivity-stimulated Aβ secretion. These findings implicate Plk2 as a novel mediator of activity-dependent APP amyloidogenic processing.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Amyloidogenic processing; Hyperexcitation; Neurodegeneration; Neuronal signaling; Polo-like kinase 2; Synaptic plasticity

Mesh:

Substances:

Year:  2017        PMID: 28257888      PMCID: PMC5414040          DOI: 10.1016/j.neuropharm.2017.02.027

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  48 in total

1.  Requirement for Plk2 in orchestrated ras and rap signaling, homeostatic structural plasticity, and memory.

Authors:  Kea Joo Lee; Yeunkum Lee; Aaron Rozeboom; Ji-Yun Lee; Noriko Udagawa; Hyang-Sook Hoe; Daniel T S Pak
Journal:  Neuron       Date:  2011-03-10       Impact factor: 17.173

2.  Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory.

Authors:  Randy L Buckner; Abraham Z Snyder; Benjamin J Shannon; Gina LaRossa; Rimmon Sachs; Anthony F Fotenos; Yvette I Sheline; William E Klunk; Chester A Mathis; John C Morris; Mark A Mintun
Journal:  J Neurosci       Date:  2005-08-24       Impact factor: 6.167

3.  Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy.

Authors:  Rimante Minkeviciene; Sylvain Rheims; Marton B Dobszay; Misha Zilberter; Jarmo Hartikainen; Lívia Fülöp; Botond Penke; Yuri Zilberter; Tibor Harkany; Asla Pitkänen; Heikki Tanila
Journal:  J Neurosci       Date:  2009-03-18       Impact factor: 6.167

4.  Tyr(682) in the intracellular domain of APP regulates amyloidogenic APP processing in vivo.

Authors:  Alessia P M Barbagallo; Richard Weldon; Robert Tamayev; Dawang Zhou; Luca Giliberto; Oded Foreman; Luciano D'Adamio
Journal:  PLoS One       Date:  2010-11-16       Impact factor: 3.240

5.  Synaptic NMDA receptor activation stimulates alpha-secretase amyloid precursor protein processing and inhibits amyloid-beta production.

Authors:  Sarah E Hoey; Robert J Williams; Michael S Perkinton
Journal:  J Neurosci       Date:  2009-04-08       Impact factor: 6.167

Review 6.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

7.  Activity-induced Polo-like kinase 2 is required for homeostatic plasticity of hippocampal neurons during epileptiform activity.

Authors:  Daniel P Seeburg; Morgan Sheng
Journal:  J Neurosci       Date:  2008-06-25       Impact factor: 6.167

8.  GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides.

Authors:  Christopher J Phiel; Christina A Wilson; Virginia M-Y Lee; Peter S Klein
Journal:  Nature       Date:  2003-05-22       Impact factor: 49.962

9.  Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease.

Authors:  Jorge J Palop; Jeannie Chin; Erik D Roberson; Jun Wang; Myo T Thwin; Nga Bien-Ly; Jong Yoo; Kaitlyn O Ho; Gui-Qiu Yu; Anatol Kreitzer; Steven Finkbeiner; Jeffrey L Noebels; Lennart Mucke
Journal:  Neuron       Date:  2007-09-06       Impact factor: 17.173

Review 10.  Phosphorylation of APP-CTF-AICD domains and interaction with adaptor proteins: signal transduction and/or transcriptional role--relevance for Alzheimer pathology.

Authors:  Gennaro Schettini; Stefano Govoni; Marco Racchi; Guido Rodriguez
Journal:  J Neurochem       Date:  2010-11-04       Impact factor: 5.372

View more
  8 in total

1.  Identification of Functional Genetic Variants Associated With Alcohol Dependence and Related Phenotypes Using a High-Throughput Assay.

Authors:  Kriti S Thapa; Andy B Chen; Dongbing Lai; Xiaoling Xuei; Leah Wetherill; Jay A Tischfield; Yunlong Liu; Howard J Edenberg
Journal:  Alcohol Clin Exp Res       Date:  2020-11-17       Impact factor: 3.455

Review 2.  What goes up must come down: homeostatic synaptic plasticity strategies in neurological disease.

Authors:  Emily A André; Patrick A Forcelli; Daniel Ts Pak
Journal:  Future Neurol       Date:  2018-01-17

3.  Central Cholinergic Synapse Formation in Optimized Primary Septal-Hippocampal Co-cultures.

Authors:  Sarra Djemil; Claire R Ressel; Mai Abdel-Ghani; Amanda K Schneeweis; Daniel T S Pak
Journal:  Cell Mol Neurobiol       Date:  2020-08-28       Impact factor: 5.046

4.  Phosphorylation of the amyloid precursor protein (APP) at Ser-675 promotes APP processing involving meprin β.

Authors:  Preeti Kumaran Menon; Niina Anneli Koistinen; Kerstin Iverfeldt; Anna-Lena Ström
Journal:  J Biol Chem       Date:  2019-10-11       Impact factor: 5.157

Review 5.  Polo-Like Kinase 2: From Principle to Practice.

Authors:  Chuanyong Zhang; Chuangye Ni; Hao Lu
Journal:  Front Oncol       Date:  2022-07-08       Impact factor: 5.738

6.  Arc Regulates Transcription of Genes for Plasticity, Excitability and Alzheimer's Disease.

Authors:  How-Wing Leung; Gabriel Foo; Antonius VanDongen
Journal:  Biomedicines       Date:  2022-08-11

Review 7.  Phosphorylation Signaling in APP Processing in Alzheimer's Disease.

Authors:  Tao Zhang; Dongmei Chen; Tae Ho Lee
Journal:  Int J Mol Sci       Date:  2019-12-27       Impact factor: 5.923

8.  RAPGEF2 mediates oligomeric Aβ-induced synaptic loss and cognitive dysfunction in the 3xTg-AD mouse model of Alzheimer's disease.

Authors:  You-Na Jang; HoChung Jang; Gyu Hyun Kim; Jeong-Eun Noh; Keun-A Chang; Kea Joo Lee
Journal:  Neuropathol Appl Neurobiol       Date:  2021-01-06       Impact factor: 8.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.